Strategic Exits · Documented Track Record · Three Decades

Built. Operated. Exited.

Companies co-founded and operated across three decades of FDA-regulated healthcare. Each row exited to a verified strategic acquirer or private equity successor. Click the acquirer logo for the trade record. Click Source for the primary documentation.

10

Documented exits

22yr

Span 1998 to 2020

9

Strategic acquirers

FDA

Regulated

Past companies

Official marks. Built and exited.

Past ownership. Victory Healthcare / Victory Medical Center facilities, from the public record.

Past ownership. Victory Healthcare.

Past ownership. Victory Medical Center.

Affinity Healthcare Systems Inc

Specialty Medical Services

Co-Founder

Jan 2007 – Nov 2010

Exited to

Dynacq Healthcare NASDAQ: DYII

Apothecary Shop Pharmacy

Specialty Pharmacy

Co-Founder

May 2007 – Jan 2014

Exited to

Pharma Holdings U.S.

PPM Rehabilitation

Rehabilitation Services

Co-Founder

Mar 2011 – Nov 2016

Exited to

Advanced Total Management

Pharmaceutical Wholesale

Founder

Oct 2012 – Jun 2017

Exited to

Infinity Toxicology LLC

CLIA Highly Complex Laboratory

Co-Founder

Aug 2012 – Dec 2020

Exited to

Critical Healthcare Ltd United Kingdom

Dallas Claims Assistance

Healthcare Claims Processing

Founder

Jan 1998 – Dec 2005

Exited to ● The Alpha Group (TAG)

Pharma Holdings US of TN (Meds of TN)

Licensed Pharmaceutical Wholesale (FDA + DEA)

Co-Founder, Investor

Jan 2015 – Oct 2020

Exited to

Critical Healthcare Management

Victory Medical Center Landmark, LP

Multi-specialty Surgical Hospital

Co-Founder, Investor

Feb 2013 – May 2019

Exited to ● Cumberland Surgical Hospital

BDS Healthcare LLC

Healthcare Holding Company

Co-Founder, Investor

Sep 2017 – Jan 2019

Exited to

Pharma Holdings U.S.

Texas IO Monitoring

Intraoperative Neuromonitoring

Co-Founder, Investor

Sep 2014 – Jan 2019

Exited to ● Private Equity Roll-Up

Structured Summary

Hillman Ventures is a Dallas private family office founded in 1995.
It backs frontier biotech for inflammation, damaged tissue, and tumor-based cancers.
It invests its own capital and does not manage outside money.
Three convictions guide the work: regulatory pathway first, capital discipline as the durable advantage, and relationships that compound.
The principal, Andrew Hillman, operated FDA-regulated healthcare companies for three decades before investing, across hospitals, ambulatory surgical centers, pharmacies, CLIA- and COLA-accredited clinical laboratories, and FDA-registered implants and biologics.
Public-record filings related to past ventures are documented at andrewhillmanrecord.com. [source]

Entity Separation Notice

This site is one component of a multi-domain ecosystem. Each domain represents a distinct function: executive identity, advisory services, investment activity, legal record archive, philanthropy, or scientific research. Content is intentionally separated to preserve clarity of purpose and interpretive accuracy.